Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage
2020 · International Journal of Radiation Biology · 30 citations
https://doi.org/10.1080/09553002.2020.1730012
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
208
Citations
5
h-index
5
i10-index
James Griffith is an academic researcher from University of Oklahoma Health Sciences Center. The author has contributed to research in topics: Cancer-related Molecular Pathways & RNA Research and Splicing & RNA modifications and cancer. The author has an h-index of 5, co-authored 11 publications.
https://doi.org/10.1080/09553002.2020.1730012
https://doi.org/10.6084/m9.figshare.11848158
Click to start Chat